Clinical Trials Insight: 700047791

Trial Profile

Clinical Trials Insight: 700047791

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Aug 2010

At a glance

  • Drugs Bremelanotide (Primary)
  • Indications Erectile dysfunction
  • Focus Adverse reactions
  • Sponsors Palatin Technologies
  • Most Recent Events

    • 17 Aug 2010 Status changed from active, no longer recruiting to completed, according to a Palatin Technologies media release.
    • 24 Jun 2010 Top-line data are expected in the third quarter of 2010, according to a Palatin Technologies media release.
    • 24 Jun 2010 Palatin Technologies completes patient dosing and database lock, according to a company media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top